RAD51 135G>C polymorphism and breast cancer risk: A meta-analysis

Breast Cancer Research and Treatment

Volumn 125, Issue 2, 2011, Pages 529-535

  Zhou, Guo Wu ^a   Hu, Jia ^a   Peng, Xu Dong ^b   Li, Qiang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Chinese PLA   (China)

Author keywords

Breast cancer; Gene polymorphism; Meta analysis; RAD51

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; ETHNICITY; FAMILY HISTORY; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HETEROZYGOTE; HUMAN; ONCOGENE; PRIORITY JOURNAL; RAD51 GENE; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; TUMOR SUPPRESSOR GENE;

AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JEWS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RAD51 RECOMBINASE; RISK; RISK FACTORS;

EID: 78650972433     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1031-8     Document Type: Article

References (38)

1. DJ Hughes 2008 Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers Fam Cancer 7 233 244 10.1007/s10689-008-9181-0 1:CAS:528:DC%2BD1cXptVKksbs%3D 10.1007/s10689-008- 9181-0 18283561
2. P Baumann SC West 1998 Role of the human RAD51 protein in homologous recombination and double-stranded-break repair Trends Biochem Sci 23 247 251 10.1016/S0968-0004(98)01232-8 1:CAS:528:DyaK1cXkvFClsbo%3D 10.1016/S0968- 0004(98)01232-8 9697414 (Pubitemid 28343368)
3. J Thacker 2005 The RAD51 gene family, genetic instability and cancer Cancer Lett 219 125 135 10.1016/j.canlet.2004.08.018 1:CAS:528: DC%2BD2MXhsVOgu7w%3D 10.1016/j.canlet.2004.08.018 15723711 (Pubitemid 40269475)
4. L Hasselbach S Haase D Fischer HC Kolberg HW Sturzbecher 2005 Characterisation of the promoter region of the human DBA-repair gene RAD51 Eur J Gynaecol Oncol 26 589 598 1:STN:280:DC%2BD28%2FhtFyrug%3D%3D 16398215
5. WW Wang AB Spurdle P Kolachana B Bove B Modan SM Ebbers G Suthers MA Tucker DJ Kaufman MM Doody RE Tarone M Daly H Levavi H Pierce A Chetrit GH Yechezkel G Chenevix-Trench K Offit AK Godwin JP Struewing 2001 A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers Cancer Epidemiol Biomarkers Prev 10 955 960 1:CAS:528:DC%2BD3MXnt1Gis7g%3D 11535547
6. L Kadouri Z Kote-Jarai A Hubert F Durocher D Abeliovich B Glaser T Hamburger RA Eeles T Peretz 2004 A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers Br J Cancer 90 2002 2005 10.1038/sj.bjc.6601837 1:CAS:528:DC%2BD2cXjvVals7s%3D 10.1038/sj.bjc.6601837 15138485 (Pubitemid 38746344)
7. E Levy-Lahad A Lahad S Eisenberg E Dagan T Paperna L Kasinetz R Catane B Kaufman U Beller P Renbaum R Gershoni-Baruch 2001 A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers Proc Natl Acad Sci USA 98 3232 3236 10.1073/pnas.051624098 1:CAS:528:DC%2BD3MXit1alsLg%3D 10.1073/pnas.051624098 11248061 (Pubitemid 32220828)
8. Antoniou AC, Sinilnikova OM, Simard J, Léoné M, Dumont M, Neuhausen SL, Struewing JP, Stoppa-Lyonnet D, Barjhoux L, Hughes DJ, Coupier I, Belotti M, Lasset C, Bonadona V, Bignon YJ; Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers Study (GEMO), Rebbeck TR, Wagner T, Lynch HT, Domchek SM, Nathanson KL, Garber JE, Weitzel J, Narod SA, Tomlinson G, Olopade OI, Godwin A, Isaacs C, Jakubowska A, Lubinski J, Gronwald J, Górski B, Byrski T, Huzarski T, Peock S, Cook M, Baynes C, Murray A, Rogers M, Daly PA, Dorkins H; Epidemiological Study of BRCA1 and BRCA2 Mutation Carriers (EMBRACE), Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Niederacher D, Deissler H; German Consortium for Hereditary Breast and Ovarian Cancer (GCHBOC), Spurdle AB, Chen X, Waddell N, Cloonan N; Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab), Kirchhoff T, Offit K, Friedman E, Kaufmann B, Laitman Y, Galore G, Rennert G, Lejbkowicz F, Raskin L, Andrulis IL, Ilyushik E, Ozcelik H, Devilee P, Vreeswijk MP, Greene MH, Prindiville SA, Osorio A, Benitez J, Zikan M, Szabo CI, Kilpivaara O, Nevanlinna H, Hamann U, Durocher F, Arason A, Couch FJ, Easton DF, Chenevix-Trench G; Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) (2007) RAD51 135G > C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet 81:1186-1200. doi: 10.1086/522611
9. A Jakubowska K Jaworska C Cybulski A Janicka J Szymańska-Pasternak M Lener SA Narod J Lubiński IHCC-Breast Cancer Study Group 2009 Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers? Eur J Cancer 45 837 842 10.1016/j.ejca.2008.10.021 1:CAS:528:DC%2BD1MXisl2rsLY%3D 10.1016/j.ejca.2008.10.021 19071013
10. S Costa D Pinto D Pereira H Rodrigues J Cameselle-Teijeiro R Medeiros F Schmitt 2007 DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population Breast Cancer Res Treat 103 209 217 10.1007/s10549-006-9364-z 1:CAS:528:DC%2BD2sXltlaqtrY%3D 10.1007/s10549-006-9364-z 17063276 (Pubitemid 46789140)
11. A Jakubowska SA Narod DE Goldgar M Mierzejewski B Masojć K Nej J Huzarska T Byrski B Górski J Lubiński 2003 Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland Cancer Epidemiol Biomarkers Prev 12 457 459 1:CAS:528:DC%2BD3sXjsleiur8%3D 12750242
12. A Jakubowska J Gronwald J Menkiszak B Górski T Huzarski T Byrski L Edler J Lubiñski RJ Scott U Hamann 2007 The RAD51 135G > C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers Cancer Epidemiol Biomarkers Prev 16 270 275 10.1158/1055-9965.EPI-06-0562 1:CAS:528:DC%2BD2sXhs1yls7Y%3D 10.1158/1055-9965.EPI-06-0562 17301259 (Pubitemid 46383345)
13. RM Dufloth S Costa F Schmitt LC Zeferino 2005 DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil Genet Mol Res 4 771 782 1:CAS:528: DC%2BD28Xht1Slsbo%3D 16475125
14. N Mantel W Haenszel 1959 Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 719 748 1:STN:280:DyaG1M%2FosVOhtQ%3D%3D 13655060
15. R DerSimonian N Laird 1986 Meta-analysis in clinical trials Control Clin Trials 7 177 188 1:STN:280:DyaL2s7gsVamtA%3D%3D 10.1016/0197-2456(86)90046-2 3802833 (Pubitemid 17189972)
16. WG Cochran 1954 The combination of estimates from different experiments Biometrics 10 101 129 10.2307/3001666
17. A Tobias 1999 Assessing the influence of a single study in the meta-analysis estimate Stata Tecnol Bull 8 15 17
18. M Egger SG Davey M Schneider C Minder 1997 Bias in meta-analysis detected by a simple, graphical test BMJ 315 629 634 1:STN:280:DyaK2svls1KjtA%3D%3D 9310563
19. I Gal G Kimmel R Gershoni-Baruch MZ Papa E Dagan R Shamir E Friedman 2006 A specific RAD51 haplotype increases breast cancer risk in Jewish non-Ashkenazi high-risk women Eur J Cancer 42 1129 1134 10.1016/j.ejca.2005.09.035 1:CAS:528:DC%2BD28Xks1ertbY%3D 10.1016/j.ejca.2005.09.035 16624550
20. H Romanowicz-Makowska B Smolarz A Kulig 2005 Germline BRCA1 mutations and G/C polymorphism in the 5'-untranslated region of the RAD51 gene in Polish women with breast cancer Pol J Pathol 56 161 165 16477874
21. H Romanowicz-Makowska B Smolarz 2006 Analysis of loss of heterozygosity and microsatellite instability RAD52, RAD54 and RAD54B gene and BRCA1 gene mutation in breast cancer Pol Merkur Lekarski 21 548 550 1:CAS:528: DC%2BD2sXjtVCms78%3D 17405295 Polish
22. H Romanowicz-Makowska B Smolarz A Kulig 2006 The G/C polymorphism of RAD51 gene in breast cancer Pol Merkur Lekarski 21 55 58 1:CAS:528: DC%2BD28XhtVyrsLrJ 17007294 Polish
23. J Blasiak K Przybyłowska A Czechowska M Zadrozny T Pertyński J Rykała A Kołacińska Z Morawiec J Drzewoski 2003 Analysis of the G/C polymorphism in the 5'-untranslated region of the RAD51 gene in breast cancer Acta Biochim Pol 50 249 253 1:CAS:528:DC%2BD3sXjt1Sru7g%3D 12673366
24. H Romanowicz-Makowska B Smolarz M Zadrozny A Kulig 2006 Analysis of RAD51 polymorphism and BRCA1 mutations in Polish women with breast cancer Exp Oncol 28 156 159 1:CAS:528:DC%2BD28XotlSrsrg%3D 16837909
25. E Synowiec J Stefanska Z Morawiec J Blasiak K Wozniak 2008 Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients Mutat Res 648 65 72 10.1016/j.mrfmmm.2008.09.014 1:CAS:528:DC%2BD1cXhsVWmtL7F 18977234
26. R Krupa E Synowiec E Pawlowska Z Morawiec A Sobczuk M Zadrozny K Wozniak J Blasiak 2009 Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer Exp Mol Pathol 87 32 35 10.1016/jyexmp2009.04.005 1:CAS:528:DC%2BD1MXotFOrt7w%3D 10.1016/j.yexmp.2009.04.005 19426727
27. L Jara ML Acevedo R Blanco VG Castro T Bravo F Gómez E Waugh O Peralta E Cabrera JM Reyes S Ampuero P González-Hormazábal 2007 RAD51 135G > C polymorphism and risk of familial breast cancer in a South American population Cancer Genet Cytogenet 178 65 69 10.1016/j.cancergencyto. 2007.05.024 1:CAS:528:DC%2BD2sXhtVOgtbfP 10.1016/j.cancergencyto.2007.05.024 17889711 (Pubitemid 47419037)
28. T Sliwinski R Krupa I Majsterek J Rykala A Kolacinska Z Morawiec J Drzewoski M Zadrozny J Blasiak 2005 Polymorphisms of the BRCA2 and RAD51 genes in breast cancer Breast Cancer Res Treat 94 105 109 10.1007/s10549-005-0672-5 1:CAS:528:DC%2BD2MXhtFKktr3K 10.1007/s10549-005-0672-5 16261408 (Pubitemid 41547106)
29. Jara L, Dubois K, Gaete D, de Mayo T, Ratkevicius N, Bravo T, Margarit S, Blanco R, Gómez F, Waugh E, Peralta O, Reyes JM, Ibáñez G, González-Hormazábal P (2010) Variants in DNA double-strand break repair genes and risk of familial breast cancer in a South American population. Breast Cancer Res Treat. doi: 10.1007/s10549-009-0709-2
30. B Kuschel A Auranen S McBride KL Novik A Antoniou JM Lipscombe NE Day DF Easton BA Ponder PD Pharoah A Dunning 2002 Variants in DNA double-strand break repair genes and breast cancer susceptibility Hum Mol Genet 11 1399 1407 10.1093/hmg/11.12.1399 1:CAS:528:DC%2BD38XksFWmsL8%3D 10.1093/hmg/11.12.1399 12023982
31. KM Lee JY Choi C Kang CP Kang SK Park H Cho DY Cho KY Yoo DY Noh SH Ahn CG Park Q Wei D Kang 2005 Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk Clin Cancer Res 11 4620 4626 10.1158/1078-0432.CCR-04-2534 1:CAS:528:DC%2BD2MXltFeksLk%3D 10.1158/1078-0432.CCR-04-2534 15958648 (Pubitemid 40825653)
32. PM Webb JL Hopper B Newman X Chen L Kelemen GG Giles MC Southey G Chenevix-Trench AB Spurdle 2005 Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer Cancer Epidemiol Biomarkers Prev 14 319 323 10.1158/1055-9965.EPI-04-0335 1:CAS:528:DC%2BD2MXhs1Ghsrc%3D 10.1158/1055-9965.EPI-04-0335 15734952 (Pubitemid 40270091)
33. TW Chang SM Wang YL Guo PC Tsai CJ Huang W Huang 2006 Glutathione S-transferase polymorphisms associated with risk of breast cancer in southern Taiwan Breast 15 754 761 10.1016/j.breast.2006.03.008 10.1016/j.breast.2006.03. 008 16713266 (Pubitemid 44774242)
34. J Brooks RE Shore A Zeleniuch-Jacquotte D Currie Y Afanasyeva KL Koenig AA Arslan P Toniolo I Wirgin 2008 Polymorphisms in RAD51, XRCC2, and XRCC3 are not related to breast cancer risk Cancer Epidemiol Biomarkers Prev 17 1016 1019 10.1158/1055-9965.EPI-08-0065 1:CAS:528:DC%2BD1cXkslGqtb8%3D 10.1158/1055-9965.EPI-08-0065 18398049 (Pubitemid 351536441)
35. R Hu Y Wei WJ Jiang WX Yao QM Long JH Zhang Y Liang XL Tang 2008 Association of polymorphisms of N372H in BRCA2 gene and 135G/C in RAD51 gene and breast cancers Sichuan Da Xue Xue Bao Yi Xue Ban 39 973 975 1:CAS:528:DC%2BD1MXks12mtw%3D%3D 19253839 Chinese
36. Akisik E, Yazici H, Dalay N (2010) ARLTS1, MDM2 and RAD51 gene variations are associated with familial breast cancer. Mol Biol Rep. doi: 10.1007/s11033-010-0113-3
37. R Wooster BL Weber 2003 Breast and ovarian cancer N Engl J Med 348 2339 2347 10.1056/NEJMra012284 1:CAS:528:DC%2BD3sXkt1Kktrc%3D 10.1056/NEJMra012284 12788999 (Pubitemid 36638109)
38. JA Berlin J Santanna CH Schmid LA Szczech HI Feldman Anti-Lymphocyte Antibody Induction Therapy Study Group 2002 Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head Stat Med 21 371 387 10.1002/sim.1023 11813224 (Pubitemid 34144648)